TBPH- Theravance Biopharma, Inc.

Over the past 90 days, insiders at Theravance Biopharma, Inc. (TBPH) have been net sellers, shedding 13,314 shares worth roughly $227K on balance.

TBPH sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Samaha Eli	9.17M	$155.98M	-
CFO	Sawaf Aziz	131.9K	-	-
VP	Grimaud Brett A.	131.3K	-	-
VP	Miller Aine	96.7K	-	-
VP	Farnum Rhonda	89.1K	-	-

Buys and sells only

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 1, 2022	Graham Richard A71	SVP, Research &Development	Sell	2,084	$10.73	$22,361.32	-0.7%	-7.0%	-1.4%
Nov 18, 2022	Hindman Andrew A.	SVP, Chief Financial Officer	Sell	65,000	$11.02	$716,241.50	-13.7%	-5.9%	-3.7%
Aug 16, 2022	Graham Richard A71	SVP, Development	Sell	4,906	$9.71	$47,639.71	-1.3%	+14.9%	-0.8%
Aug 9, 2022	Graham Richard A71	SVP, Development	Sell	15,086	$8.79	$132,605.94	-3.9%	+11.7%	+13.3%
May 23, 2022	Farnum Rhonda51	SVP, Comm &Medical Affairs	Sell	1,081	$8.93	$9,653.33	-0.3%	-3.5%	+17.4%
Feb 28, 2022	Farnum Rhonda51	SVP, Comm &Medical Affairs	Sell	2,356	$10.16	$23,946.62	-0.7%	-12.8%	+7.2%
Mar 9, 2021	Worboys Philip D	SVP, Research &Transl Science	Sell	8,829	$20.00	$176,580.00	-2.5%	-	-
Dec 14, 2020	Graham Richard A71	SVP, Development	Sell	7,500	$19.47	$146,058.00	-5.7%	-	-
Dec 3, 2020	Worboys Philip D	SVP, Research &Transl Science	Sell	4,246	$18.00	$76,428.00	-1.3%	-	-
Aug 21, 2020	Haumann Brett K	Chief Medical Officer	Sell	25,000	$18.29	$457,240.00	-8.1%	-	-